Clinical Trial

Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This Phase II Trial is Meant to Evaluate the Efficacy, and Safety of JYB1904 Injection in Patients With Perennial Allergic Rhinitis.
Trial Details
NCT Number NCT07459452
Lead Sponsor Jemincare
Conditions Perennial Allergic Rhinitis
Enrollment 135 participants
Start Date 2026-04
Primary Completion 2027-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-09